The challenge of recurrent follicular lymphoma. [Lancet Oncol. 2011] - PubMed

Save items

loading

Related citations in PubMed

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. [Lancet Oncol. 2011]
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
Coiffier B, Osmanov EA, Hong X, Scheliga A, Mayer J, Offner F, Rule S, Teixeira A, Walewski J, de Vos S, et al. Lancet Oncol. 2011 Aug; 12(8):773-84. Epub 2011 Jul 1.
Review [Malignant lymphoma: individualized treatment according to biological and clinical risk factors]. [Dtsch Med Wochenschr. 2011]
Review [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
Dreyling M. Dtsch Med Wochenschr. 2011 Apr; 136(14):687-90. Epub 2011 Mar 29.
Classification updates and clinical investigations in indolent non-Hodgkin lymphoma. [Clin Adv Hematol Oncol. 2008]
Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD. Clin Adv Hematol Oncol. 2008 Sep; 6(9):4-6.
Chemotherapy: maintenance rituximab for relapsed follicular lymphoma. [Nat Rev Clin Oncol. 2010]
Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Wrench D, Montoto S. Nat Rev Clin Oncol. 2010 Dec; 7(12):677-8.
Review [Current treatment of follicular lymphoma]. [Rev Med Suisse. 2009]
Review [Current treatment of follicular lymphoma].
Bonnet C, Beguin Y, Deprijck B, de Leval L, Fillet G. Rev Med Suisse. 2009 Aug 26; 5(214):1663-7.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The challenge of recurrent follicular lymphoma.
The challenge of recurrent follicular lymphoma.
Lancet Oncol. 2011 Aug ;12(8):714-6. Epub 2011 Jul 1 .

PubMed
Epstein-Barr virus and breast cancer: serological study in a high-incidence area...
Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma.
Cancer Lett. 2011 Oct 28 ;309(2):128-36. Epub 2011 Jun 24 .

PubMed
Don't forget family planning.
Don't forget family planning.
Lancet. 2011 Jul 2 ;378(9785):29.

PubMed
A new era for global tuberculosis control?
A new era for global tuberculosis control?
Lancet. 2011 Jul 2 ;378(9785):2.

PubMed
Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, vir...
Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers.
J Infect Dis. 1990 Dec ;162(6):1277-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The challenge of recurrent follicular lymphoma.

Source

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information